Breast cancer stem cells and epithelial mesenchymal plasticity - Implications for chemoresistance.
暂无分享,去创建一个
Mark Waltham | Erik W Thompson | M. Waltham | Cletus Pinto | E. Widodo | E. Thompson | Cletus A Pinto | Edwin Widodo
[1] S L Schor,et al. Cell proliferation and migration on collagen substrata in vitro. , 1980, Journal of cell science.
[2] Giuseppe Naso,et al. Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients , 2011, Breast Cancer Research and Treatment.
[3] F. Bertucci,et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. , 2009, Cancer research.
[4] Wen-juan Wang,et al. Twist1-Mediated Adriamycin-Induced Epithelial-Mesenchymal Transition Relates to Multidrug Resistance and Invasive Potential in Breast Cancer Cells , 2009, Clinical Cancer Research.
[5] Maximilian Reichert,et al. EMT and Dissemination Precede Pancreatic Tumor Formation , 2012, Cell.
[6] P. Wade,et al. Aberrant Expression of the Transcription Factors Snail and Slug Alters the Response to Genotoxic Stress , 2004, Molecular and Cellular Biology.
[7] Sanda Šulić,et al. Inactivation of S6 ribosomal protein gene in T lymphocytes activates a p53-dependent checkpoint response. , 2005, Genes & development.
[8] C. Kuperwasser,et al. Human breast cancer stem cell markers CD44 and CD24: enriching for cells with functional properties in mice or in man? , 2007, Breast Cancer Research.
[9] Jiri Zavadil,et al. TGF-β and epithelial-to-mesenchymal transitions , 2005, Oncogene.
[10] Jason I. Herschkowitz,et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer , 2010, Breast Cancer Research.
[11] T. Golde,et al. Targeting Notch to Target Cancer Stem Cells , 2010, Clinical Cancer Research.
[12] J. Clements,et al. Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progression , 2007, Journal of cellular physiology.
[13] I. Tinhofer,et al. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition , 2012, BMC Cancer.
[14] Charles M Perou,et al. A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer. , 2009, Cancer research.
[15] O. Eremin,et al. Breast cancer chemoresistance: emerging importance of cancer stem cells. , 2010, Surgical oncology.
[16] J. Visvader,et al. Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. , 2009, Genes & development.
[17] G. Hortobagyi,et al. Biphasic metaplastic sarcomatoid carcinoma of the breast. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[18] Michael Kahn,et al. Targeting Wnt Signaling: Can We Safely Eradicate Cancer Stem Cells? , 2010, Clinical Cancer Research.
[19] M. Waltham,et al. Epithelial mesenchymal transition traits in human breast cancer cell lines , 2008, Clinical & Experimental Metastasis.
[20] D. Tarin,et al. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? , 2005, Cancer research.
[21] Gema Moreno-Bueno,et al. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. , 2008, Cancer research.
[22] G. Opelz,et al. Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells. , 2009, Biochemical and biophysical research communications.
[23] Wenjun Guo,et al. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.
[24] B. Vincenzi,et al. Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal , 2011, Journal of cellular and molecular medicine.
[25] M. Quinn,et al. Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer. , 2010, Current cancer drug targets.
[26] Chia‐cheng Chang. Recent translational research: stem cells as the roots of breast cancer , 2006, Breast Cancer Research.
[27] Nicholas J. Wang,et al. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. , 2009, Cancer research.
[28] J. Foidart,et al. A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer , 2012, Oncogene.
[29] Jeffrey M. Rosen,et al. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features , 2009, Proceedings of the National Academy of Sciences.
[30] Raghu Kalluri,et al. The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.
[31] M. Goodell,et al. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[32] R. Mason,et al. TGF-β1 induces human alveolar epithelial to mesenchymal cell transition (EMT) , 2005, Respiratory research.
[33] L. Frati,et al. Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[34] A. Ashworth,et al. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. , 2010, Cell stem cell.
[35] K. Polyak,et al. Intra-tumour heterogeneity: a looking glass for cancer? , 2012, Nature Reviews Cancer.
[36] F. Bertucci,et al. Gene expression profiling of breast cell lines identifies potential new basal markers , 2006, Oncogene.
[37] G. Christofori. New signals from the invasive front , 2006, Nature.
[38] A. Pintzas,et al. Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic. , 2009, Biochimica et biophysica acta.
[39] L. Allen. Stem cells. , 2003, The New England journal of medicine.
[40] Sabine Riethdorf,et al. Circulating Tumor Cells and Bone Marrow Micrometastasis , 2008, Clinical Cancer Research.
[41] H. Coley. Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer. , 2008, Cancer treatment reviews.
[42] S. Fulda. Tumor resistance to apoptosis , 2009, International journal of cancer.
[43] I. Weissman,et al. Therapeutic implications of cancer stem cells. , 2004, Current opinion in genetics & development.
[44] D. Radisky,et al. Matrix metalloproteinase-induced epithelial-mesenchymal transition: tumor progression at Snail's pace. , 2007, The international journal of biochemistry & cell biology.
[45] Raghu Kalluri,et al. The epithelial–mesenchymal transition: new insights in signaling, development, and disease , 2006, The Journal of cell biology.
[46] M. Nieto,et al. The Snail genes as inducers of cell movement and survival: implications in development and cancer , 2005, Development.
[47] J. Benítez,et al. Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas , 2006, Journal of Clinical Pathology.
[48] N. Stanietsky,et al. The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity , 2009, Proceedings of the National Academy of Sciences.
[49] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[50] M. Wicha,et al. Targeting breast cancer stem cells. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[51] Ben S. Wittner,et al. A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations , 2010, Cell.
[52] E. Lander,et al. Erratum: Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudinlow and metaplastic breast cancer subtypes (Proceedings of the National Academy of Sciences of the United States of America (2010) 107:35 (15449-15454)) , 2010 .
[53] G. Z. Cheng,et al. Resistance to Paclitaxel Cells Leading to Increased Migration , Invasion , and Twist Transcriptionally Upregulates AKT 2 in Breast Cancer , 2007 .
[54] Susan G Hilsenbeck,et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. , 2008, Journal of the National Cancer Institute.
[55] Danila Coradini,et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. , 2005, Cancer research.
[56] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[57] Wenjun Guo,et al. Slug and Sox 9 Cooperatively Determine the Mammary Stem Cell State Citation , 2022 .
[58] J. Visvader,et al. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions , 2008, Nature Reviews Cancer.
[59] Jeffrey M. Skerker,et al. Loss of epithelial markers and acquisition of vimentin expression in adriamycin- and vinblastine-resistant human breast cancer cell lines. , 1992, Cancer research.
[60] G. Prindull,et al. Environmental guidance of normal and tumor cell plasticity: epithelial mesenchymal transitions as a paradigm. , 2004, Blood.
[61] Tanja Fehm,et al. Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients , 2009, Breast Cancer Research.
[62] R. Gomis,et al. Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. , 2012, The Journal of clinical investigation.
[63] J. Yates,et al. Quantitative Mass Spectrometry Identifies Drug Targets in Cancer Stem Cell‐Containing Side Population , 2008, Stem cells.
[64] Thomas Kirchner,et al. Migrating cancer stem cells — an integrated concept of malignant tumour progression , 2005, Nature Reviews Cancer.
[65] Fariba Behbod,et al. Will cancer stem cells provide new therapeutic targets? , 2005, Carcinogenesis.
[66] K. Pantel,et al. Plasticity of disseminating cancer cells in patients with epithelial malignancies , 2012, Cancer and Metastasis Reviews.
[67] A. Puisieux,et al. Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition , 2008, PloS one.
[68] D. Bowers. Strokes among childhood brain tumor survivors. , 2009, Cancer treatment and research.
[69] R. Weinberg,et al. Phenotypic plasticity and epithelial‐mesenchymal transitions in cancer and normal stem cells? , 2011, International journal of cancer.
[70] Jeffrey M. Rosen,et al. Epithelial-Mesenchymal Transition (EMT) in Tumor-Initiating Cells and Its Clinical Implications in Breast Cancer , 2010, Journal of Mammary Gland Biology and Neoplasia.
[71] G. Sherlock,et al. The prognostic role of a gene signature from tumorigenic breast-cancer cells. , 2007, The New England journal of medicine.
[72] R. Nicholson,et al. Tamoxifen resistance in MCF7 cells promotes EMT‐like behaviour and involves modulation of β‐catenin phosphorylation , 2006, International journal of cancer.
[73] Alan Wells,et al. Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition , 2010, Molecular Cancer.
[74] Michael Dean,et al. Tumour stem cells and drug resistance , 2005, Nature Reviews Cancer.
[75] M. Noble,et al. Cancer stem cells. , 2006, The New England journal of medicine.
[76] R. Maestro,et al. BRACking news on triple-negative/basal-like breast cancers: how BRCA1 deficiency may result in the development of a selective tumor subtype , 2011, Cancer and Metastasis Reviews.
[77] Andrew J Armstrong,et al. Angiogenesis , Metastasis , and the Cellular Microenvironment Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers , 2011 .
[78] J. Reis-Filho,et al. Epithelial and Mesenchymal Subpopulations Within Normal Basal Breast Cell Lines Exhibit Distinct Stem Cell/Progenitor Properties , 2012, Stem cells.
[79] R. Beroukhim,et al. Molecular definition of breast tumor heterogeneity. , 2007, Cancer cell.
[80] T. Sørlie,et al. Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity , 2012, Proceedings of the National Academy of Sciences.
[81] Wen-Lin Kuo,et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. , 2006, Cancer cell.
[82] L. Trusolino,et al. Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer , 2013, Oncogene.
[83] Jason I. Herschkowitz,et al. Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells , 2011, Proceedings of the National Academy of Sciences.
[84] G. Sauter,et al. Changes in Cytoskeletal Protein Composition Indicative of an Epithelial-Mesenchymal Transition in Human Micrometastatic and Primary Breast Carcinoma Cells , 2005, Clinical Cancer Research.
[85] F. Gonzalez-fernandez,et al. Cancer stem cell characteristics in retinoblastoma. , 2005, Molecular vision.
[86] J. Thiery,et al. Complex networks orchestrate epithelial–mesenchymal transitions , 2006, Nature Reviews Molecular Cell Biology.
[87] Paul A. Wiggins,et al. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state , 2011, Proceedings of the National Academy of Sciences.
[88] E. Hay. An overview of epithelio-mesenchymal transformation. , 1995, Acta anatomica.
[89] R. Weinberg,et al. Epithelial Mesenchymal Transition Traits in Human Breast Cancer Cell Lines Parallel the CD44hi/CD24lo/- Stem Cell Phenotype in Human Breast Cancer , 2010, Journal of Mammary Gland Biology and Neoplasia.
[90] S. Fox,et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers , 2009, Nature Medicine.
[91] Paola Chiarugi,et al. Anoikis: a necessary death program for anchorage-dependent cells. , 2008, Biochemical pharmacology.
[92] J. Settleman,et al. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer , 2010, Oncogene.
[93] M. Waltham,et al. Epithelial-to-Mesenchymal Transitions and Circulating Tumor Cells , 2010, Journal of Mammary Gland Biology and Neoplasia.
[94] Tanja Fehm,et al. Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells , 2012, Breast Cancer Research.
[95] E. Lagasse,et al. Cancer stem cells with genetic instability: the best vehicle with the best engine for cancer , 2008, Gene Therapy.
[96] J. Lieberman,et al. let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells , 2007, Cell.
[97] E. Brown,et al. Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition. , 2005, Cancer research.
[98] Sendurai A Mani,et al. The Epithelial-to-Mesenchymal Transition and Cancer Stem Cells: A Coalition Against Cancer Therapies , 2009, Journal of Mammary Gland Biology and Neoplasia.
[99] E. Thompson,et al. Mesenchymal to Epithelial Transition in Development and Disease , 2007, Cells Tissues Organs.
[100] J. Peterse,et al. Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer , 2007, Proceedings of the National Academy of Sciences.
[101] David Cameron,et al. A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer , 2009, Nature Medicine.
[102] J. Thiery,et al. Modulations of the epithelial phenotype during embryogenesis and cancer progression. , 1994, Cancer treatment and research.
[103] Yu Zhang,et al. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression. , 2012, Cancer research.
[104] A. Merchant,et al. Targeting Hedgehog — a Cancer Stem Cell Pathway , 2010, Clinical Cancer Research.
[105] I. Pogribny,et al. E‐cadherin transcriptional down‐regulation by epigenetic and microRNA‐200 family alterations is related to mesenchymal and drug‐resistant phenotypes in human breast cancer cells , 2010, International journal of cancer.
[106] P. Pelicci,et al. Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell Content , 2010, Cell.
[107] Zang Ai-hua,et al. Stem Cells,Cancer and Cancer Stem Cells , 2005 .
[108] Eric S. Lander,et al. Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening , 2009, Cell.
[109] M. Clarke,et al. Cancer stem cells: models and concepts. , 2007, Annual review of medicine.
[110] E. Lander,et al. Genetic predisposition directs breast cancer phenotype by dictating progenitor cell fate. , 2011, Cell stem cell.
[111] R. Minchin,et al. Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives , 2012, EMBO molecular medicine.
[112] E. Tiligada. Chemotherapy: induction of stress responses. , 2006, Endocrine-related cancer.